240 related articles for article (PubMed ID: 20532165)
1. Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.
Minea RO; Helchowski CM; Zidovetzki SJ; Costa FK; Swenson SD; Markland FS
PLoS One; 2010 Jun; 5(6):e10929. PubMed ID: 20532165
[TBL] [Abstract][Full Text] [Related]
2. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.
Minea R; Helchowski C; Rubino B; Brodmann K; Swenson S; Markland F
Toxicon; 2012 Mar; 59(4):472-86. PubMed ID: 21354198
[TBL] [Abstract][Full Text] [Related]
3. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
4. Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human Cancer.
Swenson SD; Silva-Hirschberg C; Markland FS
Methods Mol Biol; 2020; 2068():185-204. PubMed ID: 31576529
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
6. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
Swenson S; Costa F; Ernst W; Fujii G; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
[TBL] [Abstract][Full Text] [Related]
7. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
8. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
9. Recombinant disintegrin targets α(v) β(3) integrin and leads to mediator production.
Ribeiro LC; Massimino LC; Durante AC; Tansini A; Urbaczek AC; Selistre-de-Araújo HS; Carlos IZ
Cell Adh Migr; 2014; 8(1):60-5. PubMed ID: 24589623
[TBL] [Abstract][Full Text] [Related]
10. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis.
Yeh CH; Peng HC; Huang TF
Blood; 1998 Nov; 92(9):3268-76. PubMed ID: 9787163
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic activities of two recombinant disintegrins derived from the Mohave and Prairie rattlesnakes.
Lucena SE; Romo K; Suntravat M; Sánchez EE
Toxicon; 2014 Feb; 78():10-7. PubMed ID: 24269784
[TBL] [Abstract][Full Text] [Related]
12. Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis.
Walsh EM; Kim R; Del Valle L; Weaver M; Sheffield J; Lazarovici P; Marcinkiewicz C
Neuro Oncol; 2012 Jul; 14(7):890-901. PubMed ID: 22611032
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of a
Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
[TBL] [Abstract][Full Text] [Related]
14. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
[TBL] [Abstract][Full Text] [Related]
15. Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.
Wang WJ
Br J Pharmacol; 2010 Jul; 160(6):1338-51. PubMed ID: 20590625
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
17. Multimeric disintegrin protein polymer fusions that target tumor vasculature.
Janib SM; Gustafson JA; Minea RO; Swenson SD; Liu S; Pastuszka MK; Lock LL; Cui H; Markland FS; Conti PS; Li Z; MacKay JA
Biomacromolecules; 2014 Jul; 15(7):2347-58. PubMed ID: 24871936
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
Rüegg C; Dormond O; Mariotti A
Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
[TBL] [Abstract][Full Text] [Related]
19. Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition.
Dos Santos PK; Altei WF; Danilucci TM; Lino RLB; Pachane BC; Nunes ACC; Selistre-de-Araujo HS
Biochimie; 2020 Jul; 174():144-158. PubMed ID: 32360415
[TBL] [Abstract][Full Text] [Related]
20. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
